Thursday, October 13, 2011

Amarantus secures $10M in equity funding facility

Amarantus Biosciences said it closed a $10 million equity funding facility with Centurion Private Equity.
The Sunnyvale-based biotechnology company said it will be able to draw down on the facility over the next 36 months in tranches of up $750,000.
Amarantus Biosciences is developing biologics to treat Parkinson's and other human diseases.

No comments:

Post a Comment